Lgt Capital Partners Ltd. Haemonetics Corp Transaction History

Lgt Capital Partners Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 06, 2023	SELL	$80.84 - $89.45 $6.51 Million - $7.21 Million	-80,561 Reduced 41.86%	111,898 $9.53 Million
Q1 2023 Apr 17, 2023	SELL	$72.75 - $90.6 $7.64 Million - $9.51 Million	-105,020 Reduced 35.3%	192,459 $15.9 Million
Q4 2022 Jan 19, 2023	SELL	$73.85 - $86.14 $35 Million - $40.8 Million	-473,510 Reduced 61.42%	297,479 $0
Q3 2022 Oct 13, 2022	SELL	$63.3 - $78.66 $13.7 Million - $17.1 Million	-217,160 Reduced 21.98%	770,989 $57.1 Million
Q2 2022 Jul 13, 2022	BUY	$49.27 - $66.08 $1.07 Million - $1.43 Million	21,650 Added 2.24%	988,149 $64.4 Million
Q1 2022 Apr 13, 2022	SELL	$43.77 - $63.22 $10.9 Million - $15.8 Million	-249,560 Reduced 20.52%	966,499 $61.1 Million
Q4 2021 Jan 14, 2022	BUY	$49.55 - $74.59 $1.8 Million - $2.72 Million	36,400 Added 3.09%	1,216,059 $64.5 Million
Q3 2021 Oct 13, 2021	BUY	$57.6 - $70.59 $13 Million - $16 Million	226,234 Added 23.73%	1,179,659 $83.3 Million
Q2 2021 Jul 20, 2021	BUY	$51.81 - $118.56 $49.4 Million - $113 Million	953,425 New	953,425 $63.5 Million

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Lgt Capital Partners Ltd., based on Form 13F filings with the SEC.

Stay updated on Lgt Capital Partners Ltd. with notifications on news.